The transcription factor E2F2 regulates tumor development
Blood and Genomics · 2020 · 4 (1) · 45-52
DOI: 10.46701/bg.2020012020102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood and Genomics, 2020. Verfasst von Qianfan Liu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Cell cycle-related E2F transcription factor 2 (E2F2) is a member of the E2F transcription factor family. E2F2 is implicated in tumorigenesis as it functions as a nuclear transcription factor responsible for regulating cell cycle progression to maintain genomic integrity. In recent decades, substantial experimental evidence has associated the function of E2F2 with tumor promotion. However, this transcription factor has also been revealed to be capable of exerting tumor suppressive activities in certain tumor models. In this review, we discuss recent developments in research that focus on E2F2 with respect to tumorigenesis. We will particularly address the dynamic regulatory roles of microRNA (miRNA) on the expression of E2F2 as various miRNA species have been confirmed to have complementary binding sites in the 3' untranslated region of E2F2.
Zitieren
APA
Liu, Q., Xiang, Z., & Zhu, H. (2020). The transcription factor E2F2 regulates tumor development. Blood and Genomics, 4(1), 45-52. https://doi.org/10.46701/bg.2020012020102
Vancouver
Liu Q, Xiang Z, Zhu H. The transcription factor E2F2 regulates tumor development. Blood and Genomics. 2020;4(1):45-52. doi:10.46701/bg.2020012020102
BibTeX
@article{Liu2020,
author = {Liu, Qianfan and Xiang, Zou and Zhu, Haitao},
title = {The transcription factor E2F2 regulates tumor development},
journal = {Blood and Genomics},
year = {2020},
volume = {4},
number = {1},
pages = {45--52},
doi = {10.46701/bg.2020012020102}
}
EUVIMED